#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Brain abscess Liver abscess Activated PI3 kinase delta syndrome Adrenoleukodystrophy Necrotising myositis Antiphospholipid syndrome Adenovirus infection Hypereosinophilic syndrome Alveolar proteinosis Palmoplantar pustulosis Focal segmental glomerulosclerosis Glioma Paraneoplastic neurological syndrome Chronic inflammatory demyelinating polyradiculoneuropathy Fungal infection More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Trials in Disease Langerhans’ cell histiocytosis – Life with Disease Aicardi-Goutieres syndrome Marginal zone lymphoma – Treatment Progressive supranuclear palsy Richter’s syndrome – Diagnostics Cystic fibrosis lung – Life with Disease Angelman’s syndrome – Basic Information Glomerulonephritis membranous – Trials in Disease Uterine leiomyosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Atorvastatin Pitolisant Metformin HYDROXYCHLOROQUINE Carmustine Cangrelor Tetrasodium H2-Receptor Antagonists Clic-1901 Cart Cefotaxime Dexamethasone Sodium Phosphate Vibegron Dexamethasone Acetate Adagrasib Carbasalate Calcium Mb-Cart20.1 Atogepant Pamiparib MZE829 Midostaurin VANDETANIB More therapies…

    Learn about Your Condition

    Hand fracture Tourette's disorder Small cell lung cancer Bronchopulmonary aspergillosis Diabetes mellitus Bladder cancer stage II Fibrous dysplasia of bone Peripheral artery restenosis Fibrosarcoma metastatic Carotid artery occlusion Fibrosarcoma Postpartum haemorrhage Prostatitis Escherichia coli Ewing's sarcoma Biliary cancer metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study of Venglustat and Imiglucerase for Adult Patients with Gaucher Disease Type 3

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gaucher’s disease type I
    • Gaucher’s disease type III
    Investigated Drugs:
    • Imiglucerase
    • Venglustat
    Germany

  • Study Comparing Aficamten and Metoprolol for Adults with Symptomatic Hypertrophic Cardiomyopathy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Aficamten
    • Dobutamine Hydrochloride
    • Metoprolol Tartrate
    Denmark France Germany Hungary Italy The Netherlands +1

  • Study on the Safety and Effects of OMT-28 for Patients with Primary Mitochondrial Disease and Muscle or Heart Problems

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • 2-{[(8Z)-13-[(Methylcarbamoyl)Formamido]-Tridec-8-En-1-Yl]Oxy}Acetic Acid
    Germany Italy The Netherlands

  • Study on the Effects of EDG-5506 for Adults and Adolescents with Becker Muscular Dystrophy

    Not recruiting

    2 1
    Investigated Diseases:
    • Becker’s muscular dystrophy
    Investigated Drugs:
    • Edg-5506
    Belgium Denmark France Germany Italy The Netherlands +1

  • Long-Term Study on the Safety of Avalotcagene Ontaparvovec for Adults with Late-Onset Ornithine Transcarbamylase Deficiency

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Ornithine transcarbamoylase deficiency
    Investigated Drugs:
    • Avalotcagene Ontaparvovec
    France Spain

  • Study on the Safety and Effectiveness of BCMACP03 for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Bcmacp03
    Belgium The Netherlands
Previous Page
1 … 41 42 43 44 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!